Drug Type ASO |
Synonyms Locked nucleic acid (LNA) Gapmers |
Target |
Action inhibitors |
Mechanism Gastrin-17 inhibitors(Gastrin 17 inhibitors) |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Pancreatic Cancer | Preclinical | United States | 08 Apr 2024 | |
Pancreatic Cancer | Preclinical | United States | 08 Apr 2024 |